Symbols

EMI(IPO)

Encore Medical·AMEX

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About EMI

Encore Medical, Inc.

Industry

Healthcare Equipment and Supplies

Established Date

09/26/2017

Listing Date

04/15/2026

Exchange

American Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.encore-medical.com

Security Type

Common stock

Office address

2975 Lone Oak Drive Suite 140 Eagan MN 55121

Business

Introduction

Encore Medical, Inc., was incorporated in Minnesota on September 26, 2017. The company focuses on the field of transcatheter closure of specific heart defects and has more than two decades of experience and a deep technical foundation of expertise. Encore Medical is committed to the development, production and sales of ventricular septal defect closure products, aiming to provide efficient non-surgical repair solutions for heart defects in adults and children. Its medical devices have obtained CE certification and are currently actively expanding the market through distribution partners in countries outside the United States.

Company Financials

EPS

Revenue & Expenses

EMI has released its 2025 Q4 earnings report, with revenue of 1.30M, reflecting a YoY change of 119.27%, and net profit of -370.52K, showing a YoY change of 44.89%. The Sankey diagram below clearly presents EMI's revenue sources and cost distribution.